| Identification | Back Directory | [Name]
ONO 3708 | [CAS]
102191-05-9 | [Synonyms]
ONO 3708
(Z)-7-[(1S,5R)-3β-[[(R)-Cyclopentyl(hydroxy)acetyl]amino]-6,6-dimethylbicyclo[3.1.1]hept-2α-yl]-5-heptenoic acid
(Z)-7-[(1S,5R)-3β-[[(R)-Cyclopentylhydroxyacetyl]amino]-6,6-dimethylbicyclo[3.1.1]heptan-2α-yl]-5-heptenoic acid
5-Heptenoic acid, 7-[(1S,2S,3S,5R)-3-[[(2R)-2-cyclopentyl-2-hydroxyacetyl]amino]-6,6-dimethylbicyclo[3.1.1]hept-2-yl]-, (5Z)- | [Molecular Formula]
C23H37NO4 | [MDL Number]
MFCD01753215 | [MOL File]
102191-05-9.mol | [Molecular Weight]
391.54 |
| Hazard Information | Back Directory | [Uses]
ONO 3708 is a TXA2/PGH2 receptor antagonist that can inhibit the binding properties of U46619 in unactivated intact human platelets, with an IC50 value of 38 nM[1]. | [References]
[1] Kattelman EJ, et al. Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548). Thromb Res. 1986 Feb 15;41(4):471-81. DOI:10.1016/0049-3848(86)91692-0 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.bocsci.com |
|